Invanz and Fistula discharge - a phase IV clinical study of FDA data

Summary:

Fistula discharge is reported as a side effect among people who take Invanz (ertapenem sodium), especially for people who are male, 60+ old, also take Mobic, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Fistula discharge when taking Invanz. It is created by eHealthMe based on reports of 3,924 people who have side effects when taking Invanz from the FDA, and is updated regularly.

What is Invanz?

Invanz has active ingredients of ertapenem sodium. It is often used in urinary tract infection. eHealthMe is studying from 3,961 Invanz users. Check the latest studies of Invanz.

What is Fistula discharge?

Fistula discharge (discharge from abnormal passage of structure/organ) is found to be associated with 280 drugs and 277 conditions by eHealthMe. Check the latest studies of Fistula discharge.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

3,924 people reported to have side effects when taking Invanz.
Among them, 19 people (0.48%) have Fistula discharge.

Among these 19 people:

What is the gender of people who have Fistula discharge when taking Invanz? *

female: 5.26 %
male: 94.74 %

What is the age of people who have Fistula discharge when taking Invanz? *

What are other drugs people take besides Invanz? *

What are other side effects people have besides Fistula discharge? *

Injury: 19 people, 100.00%
Scar: 19 people, 100.00%
Bone Swelling: 19 people, 100.00%
Renal Cyst (kidney cyst): 19 people, 100.00%
Purulent Discharge (discharge that contains pus): 19 people, 100.00%
Plasmacytoma (neoplasm of plasma cells (usually in bone marrow)): 19 people, 100.00%
Physical Disability: 19 people, 100.00%
Pancreatitis (inflammation of pancreas): 19 people, 100.00%
Pain: 19 people, 100.00%
Osteoradionecrosis (irradiation of bones causes damage to osteocytes and impairs the blood supply): 19 people, 100.00%

What are the existing conditions these people have? *

Trismus (reduced opening of the jaws): 19 people, 100.00%
Multiple Myeloma (cancer of the plasma cells): 19 people, 100.00%
Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Invanz and have Fistula discharge?

- Check whether Fistula discharge is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Invanz:

Invanz (3,961 reports)

Browse all side effects of Invanz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fistula discharge:

Fistula discharge (280 drugs)

Browse all the conditions that are associated with Fistula discharge:

Fistula discharge (277 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ertapenem sodium (the active ingredients of Invanz) and Invanz (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.